MedTrace Logo

Weight Gain Prevention for Breast Cancer Survivors

NCT00533338 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2020-01-13

No results posted yet for this study

Summary

The specific aims of this study are:

1. To test the feasibility of a randomized controlled trial of a weight gain prevention program for breast cancer survivors that combines exercise and dietary changes during treatment. Feasibility will be evaluated by examining data on recruitment rate, attendance at intervention sessions, drop-out rates in both study conditions, assessment completion rates, and participant feedback.
2. To test the effect of a weight gain prevention program, compared to usual care, on weight, body composition, and biomarkers related to breast cancer prognosis.
3. To explore whether changes in physical activity, energy intake, and resting energy expenditure predict weight gain among breast cancer survivors.
4. To test the effect of a weight gain prevention program on quality of life variables.

Conditions

Interventions

BEHAVIORAL

Weight Gain Prevention Program

Intervention program including in-person instruction and counseling about exercise and diet, exercise practice sessions, and telephone counseling.

BEHAVIORAL

Questionnaire

Packet of questionnaires will be completed.

Sponsors & Collaborators

  • Lance Armstrong Foundation

    collaborator OTHER

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Karen Basen-Engquist, PhD · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-20
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00533338 on ClinicalTrials.gov